Rights issue and half year 2023 results

On 7 September 2023, alongside interim results for the for the six months ended 30 June 2023, Synthomer plc announced a proposed rights issue to support reduction in leverage and provide stronger foundations to focus on delivering its speciality solutions strategy. Please click here for information relating to the rights issue and interim results 2023.

About Synthomer

Synthomer was first listed on the London Stock Exchange in 1971 but has a history that stretches back to 1863.

We are on a journey to become a global specialised chemical company focused on three core end markets, with excellence embedded throughout our business and a sharp focus on sustainable innovation.

Our strategy is making us a trusted and responsible player in our customers’ value chains, meeting the needs of the end consumer and delivering on our purpose of creating innovative and sustainable solutions for the benefit of customers and society.

This strategy, together with our global footprint and the strengths and commitment of our talented people, means that we are well positioned to deliver on our medium term profitable growth targets.

It is all part of Synthomer’s unique chemistry.

Our investment case

There are many reasons why Synthomer is a sound proposition for investment.

Find out more